IMMUTEP LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (5-Aug) $70,738,624 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (29-Jul) 44,537,538 (3.02%) (106th) |
|
52w High $0.470 |
52w Low $0.028 |
P/E 7.20 |
EPS -0.04 |
[ARTICLE] Immutep drafts in Bell Potter, Jefferies for raising
A news article has been posted about Immutep on the AFR. The article was published around , on 17 June 2021 at 10:38am.
Cancer and auto-immune disease drug developer Immutep landed in front of fund managers on Thursday morning with a capital raising.
Read ArticleIMM was $0.62 at the close of trade on 16 June 2021
Find all articles about Immutep, including others on the AFR, on the media page.
You must be logged in to post a reply.